The Clorox Company
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 7.34B | 7.11B | 7.39B | 7.09B | 7.10B | 0.2% | |
| Cost of Revenue | (4.14B) | (4.56B) | (4.48B) | (4.04B) | (3.89B) | -3.8% | |
Gross Profit | 3.20B | 2.54B | 2.91B | 3.05B | 3.21B | 5.4% | |
| Operating Expenses | |||||||
| Research & Development | (149.00M) | (132.00M) | (138.00M) | (126.00M) | (121.00M) | -4.0% | |
| Selling, General & Administrative | (1.79B) | (1.66B) | (1.92B) | (2.17B) | (1.89B) | -12.7% | |
| General & Administrative | (1.00B) | (954.00M) | (1.18B) | (1.34B) | (1.12B) | -16.0% | |
| Selling & Marketing | (790.00M) | (709.00M) | (734.00M) | (832.00M) | (770.00M) | -7.5% | |
| Depreciation & Amortization | (211.00M) | (224.00M) | (236.00M) | (235.00M) | (219.00M) | -6.8% | |
Operating Income (EBIT) | 1.23B | 719.00M | 823.00M | 723.00M | 1.18B | 62.8% | |
| Non-Operating Items | |||||||
| Interest Income | 5.00M | 5.00M | 16.00M | 23.00M | 9.00M | -60.9% | |
| Interest Expense | (99.00M) | (106.00M) | (90.00M) | (90.00M) | (88.00M) | -2.2% | |
| Other Income/Expenses (Net) | -325.00M | -112.00M | -585.00M | -325.00M | -99.00M | -69.5% | |
Income Before Tax | 900.00M | 607.00M | 238.00M | 398.00M | 1.08B | 170.9% | |
| Income Tax Expense | (181.00M) | (136.00M) | (77.00M) | (106.00M) | (254.00M) | 139.6% | |
Net Income | 710.00M | 462.00M | 149.00M | 280.00M | 810.00M | 189.3% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $6 | $4 | $1 | $2 | $7 | 191.6% | |
| Weighted Avg Shares Outstanding | 125.57M | 123.11M | 123.59M | 124.17M | 123.53M | -0.5% | |
| Weighted Avg Shares Outstanding (Diluted) | 127.30M | 123.91M | 124.18M | 124.80M | 124.29M | -0.4% | |
EBITDA | 1.21B | 937.00M | 564.00M | 723.00M | 1.39B | 91.6% |
Explore CLX
CLX in the Consumer Defensive
Large Cap